External Advisory Board (EAB)
For external supervision and as a platform to give new stimuli to the network an international External Advisory Board (EAB) of three renowned experts of higher education in the metabolic field has been established and evaluates the IRTG-ICSMD every other year, based on an evaluation report that is compiled by the SC and the coordinator.
| Name | |
|---|---|
| Professor Jay Skyler | Jay S. Skyler, MD, MACP is a graduate of Jefferson Medical College. He did postgraduate training at Duke and NIH. He is Professor of Medicine, Pediatrics, and Psychology at the University of Miami, and Deputy Director at the Diabetes Research Institute. For 22 years (1993-2015), he was Study Chairman for the NIH Diabetes Prevention Trial for T1D (DPT-1) and its successor the T1D TrialNet. Professor Skyler was the President of ADA and the Vice-President of IDF. He was founding Editor-in-Chief of Diabetes Care and founding Scientific Editor of the International Diabetes Monitor, and is Senior Editor of Diabetes Technology & Therapeutics. |
| Professor Andrew V. Schally | Andrew V. Schally won the Nobel Prize for Medicine or Physiology in 1977, for his research on hypothalamic control of the pituitary gland. He developed a new realm of knowledge concerning the brain's endocrine control over the body’s functions. He isolated and then synthesized the neurohormone GnRH/LHRH that controls FSH and LH secretion and reproduction. Dr. Schally worked at VA Hospital and Tulane University School of Medicine in New Orleans, LA , from 1962-2005. Subsequently, he was transferred to the Miami VA Hospital and the University of Miami School of Medicine. He is now working on the application of antagonists of growth hormone-releasing hormone in the therapy of cancer, dyslipidemia, Alzheimer’s disease and on the effects of GHRH agonists in cardiology, diabetes and ophthalmology. |
| Professor Felix Beuschlein | Felix Beuschlein is Professor of Internal Medicine/Endocrinology and Director of the Clinic for Endocrinology, Diabetology and Clinical Nutrition at the University Clinic Zurich in Switzerland. He serves on several boards including the Annual Meeting Committee of the Endocrine Society and has been the vice president of the German Endocrine Society and the chairman of the Adrenal, Hypertension and Steroid – Section. The scientific interests of Professor Beuschlein mainly relate to adrenal disorders and endocrine tumors. He has authored more than 250 publications in high ranking international journals and has received a number of awards including the European Journal of Endocrinology Prize. |
| Professor Frank H. P. Fitzek |
Frank H. P. Fitzek is a Professor and head of the “Deutsche Telekom Chair of Communication Networks” at TU Dresden coordinating the 5G Lab Germany. He is the spokesman of the DFG Cluster of Excellence CeTI. He co-founded several start-up companies starting with acticom GmbH in Berlin in 1999. In 2005 he won the YRP award for the work on MIMO MDC and received the Young Elite Researcher Award of Denmark. He was selected to receive the NOKIA Champion Award several times in a row from 2007 to 2011. In 2008 he was awarded the Nokia Achievement Award for his work on cooperative networks. In 2011 he received the SAPERE AUDE research grant from the Danish government and in 2012 he received the Vodafone Innovation prize. In 2015 he was awarded the honorary degree “Doctor Honoris Causa” from Budapest University of Technology and Economics (BUTE). His current research interests are in the areas of wireless and 5G communication networks, network coding, cloud computing, compressed sensing, cross layer as well as energy efficient protocol design and cooperative networking. |
| Professor Andreas Birkenfeld | Andreas Birkenfeld was the former deputy spokesperson of the IRTG 2251 at TUD. After various career positions at Yale University, Charité Berlin, Universitätsklinkum Carl Gustav Carus Dresden and King’s College London, he took over the Chair position of the Clinic for Diabetology, Endocrinology and Nephrology at the University of Tubingen in October 2019. The scientific interests of Professor Birkenfeld are to understand the development of insulin resistance and T2D and its connection to adipositas to develop new therapeutic strategies. He has authored more than 250 publications in high ranking international journals and has received a number of awards including the Ferdinand Bertram Prize (Deutsche Diabetesgesellschaft). |